Back to Search
Start Over
Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
- Source :
- Gut Pathogens. June 6, 2022, Vol. 14 Issue 1
- Publication Year :
- 2022
-
Abstract
- Background Helicobacter pylori eradication by the conventional clarithromycin therapy has largely dropped in the recent years possibly due to antimicrobial resistance. Hence, levofloxacin-based regimen has been used as salvage therapy. However, data regarding its effectiveness on eradication are controversial. This study aimed to compare the eradication rate of levofloxacin-based regiment to that of the conventional first-line clarithromycin regimen. Methods Patients diagnosed with H. pylori infection and treated with levofloxacin triple therapy or clarithromycin-based regimen for 10 or 14 days were included. Patients were excluded if they used antibiotics or proton pump inhibitors within 4 or 2 weeks, respectively, of the H. pylori eradication confirmation test. H. pylori eradication rate was assessed, as well as the impact of diabetes and esophagogastroduodenoscopy (EGD) findings. Results Of 245 patients, 145 were in the levofloxacin group and 100 in the clarithromycin group. Most patients in either group received therapy for 14 days vs. 10 days (P = 0.002). Levofloxacin-based treatment was associated with a higher eradication rate compared with clarithromycin-based treatment (74.5 vs. 62%, respectively; P = 0.04). The 14 day levofloxacin-based regimen resulted in the highest eradication rate, followed by the 14 day regimen of clarithromycin (80.9 vs. 66.3%; P = 0.03). The 10 day regimens exhibited 62.7 and 41.2% eradication rates, respectively (P = 0.12). H. pylori eradication was not affected by diabetes or EGD findings (P = 0.98 and 0.3, respectively). Conclusions Results from this study support the use of a levofloxacin-based regimen as a first-line therapy in the treatment of H. pylori infection for 14 days regardless of diabetes and EGD findings. Keywords: Levofloxacin, Clarithromycin, Helicobacter pylori, Peptic ulcer<br />Author(s): Eman T. Azab[sup.1,3], Abrar K. Thabit[sup.2], Sean McKee[sup.1] and Aymen Al-Qiraiqiri[sup.1] Introduction Helicobacter pylori infection is one of the most common gastrointestinal infections. It is considered the primary cause [...]
- Subjects :
- Helicobacter infections -- Care and treatment
Patient compliance -- Health aspects
Drug resistance in microorganisms -- Care and treatment
Helicobacter pylori -- Health aspects
Metronidazole -- Health aspects
Levofloxacin -- Health aspects
Clarithromycin -- Health aspects
Infection -- Care and treatment
Pantoprazole -- Health aspects
Health
Subjects
Details
- Language :
- English
- ISSN :
- 17574749
- Volume :
- 14
- Issue :
- 1
- Database :
- Gale General OneFile
- Journal :
- Gut Pathogens
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.706246940
- Full Text :
- https://doi.org/10.1186/s13099-022-00502-3